Literature DB >> 8407553

Genetic changes and histopathological grades in human hepatocellular carcinomas.

M Konishi1, R Kikuchi-Yanoshita, K Tanaka, C Sato, K Tsuruta, Y Maeda, M Koike, S Tanaka, Y Nakamura, N Hattori.   

Abstract

Loss of heterozygosity (LOH) on chromosomes 1p, 4q, 5q, 8p, 13q, 16q, 17p, and 22q, and mutation of the p53 gene were simultaneously analyzed in 63 hepatocellular carcinomas (HCCs) with distinct histopathological grades, 80% of the tumors being from patients who had been exposed to hepatitis B virus (HBV) or hepatitis C virus (HCV). The frequencies of LOH on 8 chromosomes were 0-25% in 10 well differentiated HCCs, LOH being observed on 4q, 5q and 17p, 21-53% in 26 moderately differentiated HCCs, LOH on 8p and 17p being high, and 29-75% in 27 poorly differentiated HCCs, LOH on 17p, 4q and 8p being the most frequent. p53 gene mutation was detected in moderately and poorly differentiated HCCs at 15% and 52%, respectively, but not at all in well differentiated HCCs. Of the mutations detected, 42% were transition mutation and only 5% were CpG transition, in contrast to the high frequencies of these types of mutations in colon tumors (78% and 54%, respectively). LOH on every chromosome and p53 mutation were more frequent in more advanced tumors, and accumulation of genetic changes increased with increase of the histopathological grade. Frequency of genetic changes in HCCs from HBV-positive patients was comparable to that from HCV-positive patients. The present results suggest that accumulation of genetic changes in multiple tumor suppressor genes, especially LOH on 17p, 4q and 8p, and mutation in p53 gene, are involved in the progression of liver cancer, and LOH on 17p and 4q precedes other genetic changes. Differences in the direction of p53 mutation between HCC and colon carcinoma suggest that liver carcinogens are distinct from colon carcinogens. Furthermore, mechanisms affecting the frequency of LOH in HCCs in HBV-infected patients may be similar to those in HCV-infected patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407553      PMCID: PMC5919266          DOI: 10.1111/j.1349-7006.1993.tb02063.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


hepatocellular carcinoma hepatitis B virus hepatitis C virus loss of heterozygosity polymerase chain reaction single strand conformation polymorphism restriction fragment length polymorphism
  39 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Localization of the genetic defect in familial adenomatous polyposis within a small region of chromosome 5.

Authors:  Y Nakamura; M Lathrop; M Leppert; M Dobbs; J Wasmuth; E Wolff; M Carlson; E Fujimoto; K Krapcho; T Sears
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

Review 4.  Oncogene activation in chemical carcinogenesis.

Authors:  A Balmain; K Brown
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

5.  Loss of somatic heterozygosity in hepatocellular carcinoma.

Authors:  G J Walker; N K Hayward; S Falvey; W G Cooksley
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

6.  Short direct repeats flanking deletions, and duplicating insertions in p53 gene in human cancers.

Authors:  N Jego; G Thomas; R Hamelin
Journal:  Oncogene       Date:  1993-01       Impact factor: 9.867

7.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; T Sadamoto; G Isowa; K Honda; Y Yamaoka; M Ikenaga; H Imura; K Ishizaki
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

9.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

10.  Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene.

Authors:  M Karin; R I Richards
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

View more
  6 in total

1.  Tumor suppress genes screening analysis on 4q in sporadic colorectal carcinoma.

Authors:  Li-Xin Jiang; Jie Xu; Zhao-Wen Wang; Da-Peng Li; Zhi-Hai Peng; Jian-Jun Gao; Lin He; Hai-Tao Zheng
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

2.  The correlation of genetic instability of PINX1 gene to clinico-pathological features of gastric cancer in the Chinese population.

Authors:  Yingyu Ma; Liang Wu; Cuiping Liu; Liqian Xu; Dongmei Li; Ji-Cheng Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-11       Impact factor: 4.553

3.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.

Authors:  J C Sheu; Y W Lin; H C Chou; G T Huang; H S Lee; Y H Lin; S Y Huang; C H Chen; J T Wang; P H Lee; J T Lin; F J Lu; D S Chen
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

5.  Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis.

Authors:  F Niketeghad; H J Decker; W H Caselmann; P Lund; F Geissler; H P Dienes; P Schirmacher
Journal:  Br J Cancer       Date:  2001-09-01       Impact factor: 7.640

6.  Hspb1 and Tp53 Mutation and Expression Analysis in Cat Mammary Tumors.

Authors:  Rashid Saif; Ali Raza Awan; Leslie Lyons; Barbara Gandolfi; Muhammad Tayyab; Masroor Ellahi Babar; Asim Khalid Mehmood; Zia Ullah; Muhammad Wasim
Journal:  Iran J Biotechnol       Date:  2016-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.